XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Schedule of Equity Compensation Plan Information

Equity Compensation Plan Information as of March 31, 2023:

 

   Number of securities to be issued upon exercise of outstanding options, warrants and rights (a)   Weighted – average exercise price of outstanding options, warrants and rights (b)   Number of securities remaining available for future issuances under equity compensation plans (excluding securities reflected in column (a) (c) 
Equity Compensation Plans Approved by Security Holders   3,467,647   $0.0400    21,532,353 
Equity Compensation Plans Not Approved by Security Holders   230,971,520    0.0362     
Total   234,439,167   $0.0362    21,532,353 
Schedule of Valuation Assumptions of Options

The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock option awards and warrant issuances. The calculation of the fair value of the awards using the Black-Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following:

 

   Three Months ended March 31, 
   2023   2022 
Expected volatility   172.0% - 346.4%   172.0346.4%
Expected term   1.505.0 Years    1.55.0 Years 
Risk-free interest rate   0.16% - 4.64%   0.16% - 2.10%
Forfeiture rate   0.17%   0.03%
Schedule of Outstanding Stock Option Activity

A summary of the status of the Company’s outstanding stock options as of March 31, 2023 and December 31, 2022 and changes during the periods ending on such dates is as follows:

 

           Weighted     
       Weighted   Average     
       Average   Remaining   Aggregate 
  

Number of

Options

  

Exercise

Price

  

Contractual

Life in Years

  

Intrinsic

Value

 
Outstanding at December 31, 2021   233,128,266   $0.0362    2.23      
Granted   5,710,901    0.0281           
Forfeited   (400,000)   0.0354           
Exercised   -    -           
Cancelled   -    -           
Outstanding – December 31, 2022   238,439,167   $0.0360    1.43      
Exercisable – December 31, 2022   111,558,754   $0.0321    1.33   $68,994 
                     
Granted   -    -           
Forfeited   (4,000,000)   0.0229           
Exercised   -    -           
Cancelled   -    -           
Outstanding – March 31, 2023   234,439,167   $0.0362    1.21      
Exercisable – March 31, 2023   107,790,004   $0.0325    1.14   $265,633 
Summary of Exercise Price of Employee Stock Options Outstanding

The following table summarizes information about employee stock options outstanding at March 31, 2023.

 

Range of Exercise Price  Number outstanding at December 31, 2022   Weighted average remaining life   Weighted average exercise price   Number exercisable at December 31, 2022   Weighted average exercise price   Weighted average remaining life 
$ 0.018 - $0.0225   70,730,020    2.00   $0.0182    45,730,020   $0.0181    1.62 
$ 0.0229 - $0.0325   5,093,254    4.27   $0.0268    5,024,504   $0.0267    4.29 
$ 0.0360 - $0.0425   25,530,893    3.32   $0.0398    6,166,730   $0.0396    3.26 
$ 0.0440 - $0.0531   133,085,000    0.28   $0.0455    50,868,750   $0.0450    0.12 
  Outstanding options   234,439,167    1.21    0.0362    107,790,004    0.0325    1.14 
Schedule of Warrant Activity

A summary of the Company’s warrants as of December 31, 2022 and changes during the three months ended March 31, 2023 is presented below:

 

  Number of
Warrants
   Weighted
Average Exercise
Price
   Weighted
Average
Remaining
Contractual
Life in Years
   Aggregate
Intrinsic
Value
 
Outstanding – December 31, 2022   18,255,951   $0.0245    1.55   $12,000 
Granted   11,428,570   $0.0175           
Exercised   -    -           
Forfeited or Expired   -                
Outstanding – March 31, 2023   29,684,521   $0.0247    1.52      
Exercisable – March 31, 2023   29,684,521   $0.0247    1.52   $109,714